![Evaline Tsai](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Evaline Tsai
Investitore di Private Equity presso
Gigascale Capital
Profilo
Evaline Tsai was the founder of Cambridge Cancer Genomics Ltd., founded in 2016, and served as Chief Technology Officer from 2016 to 2018.
Dr. Tsai is currently a Partner at Gigascale Capital Advisors LLC, starting in 2023.
Former positions include Principal at Costanoa Venture Capital Management LLC in 2020 and Senior Associate at Fine Structure Ventures from 2021 to 2022.
Education includes a doctorate from the University of Cambridge conferred in 2019 and an undergraduate degree from Princeton University conferred in 2015.
Posizioni attive di Evaline Tsai
| Società | Posizione | Inizio |
|---|---|---|
Gigascale Capital
 Gigascale Capital Investment ManagersFinance Gigascale Capital invests in companies located in the United States. The firm targets companies operating of clean energy, advanced manufacturing, grid infrastructure and physical AI sectors. It participates in pre-seed, seed and early stage capital requirements. | Investitore di Private Equity | 01/01/2023 |
Precedenti posizioni note di Evaline Tsai
| Società | Posizione | Fine |
|---|---|---|
Fine Structure Ventures
 Fine Structure Ventures Investment ManagersFinance Fine Structure Ventures invests in companies located across the globe. The firm targets companies operating in the fields of disruptive scientific and technological innovation sectors. It provides financing for pre-seed, seed, early and later stage capital requirements. | Analista di Private Equity | 01/12/2022 |
Costanoa Venture Capital Management LLC
 Costanoa Venture Capital Management LLC Investment ManagersFinance Costanoa Ventures invests in companies located in the United States primarily in Latin America, Europe, Africa and Australia. The firm targets companies operating in the fields of fintech, data & developer infrastructure, applied AI and cyber & national security. It participates in seed and early stage transactions and also acts as lead investor. | Investitore di Private Equity | 30/11/2020 |
Cambridge Cancer Genomics Ltd.
 Cambridge Cancer Genomics Ltd. Pharmaceuticals: MajorHealth Technology Provides cancer research and therapy services | Fondatore | 31/12/2018 |
Formazione di Evaline Tsai
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
95
Relazioni di 1° grado
6
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Costanoa Venture Capital Management LLC
Costanoa Venture Capital Management LLC Investment ManagersFinance Costanoa Ventures invests in companies located in the United States primarily in Latin America, Europe, Africa and Australia. The firm targets companies operating in the fields of fintech, data & developer infrastructure, applied AI and cyber & national security. It participates in seed and early stage transactions and also acts as lead investor. | Finance |
Cambridge Cancer Genomics Ltd.
Cambridge Cancer Genomics Ltd. Pharmaceuticals: MajorHealth Technology Provides cancer research and therapy services | Health Technology |
Fine Structure Ventures
Fine Structure Ventures Investment ManagersFinance Fine Structure Ventures invests in companies located across the globe. The firm targets companies operating in the fields of disruptive scientific and technological innovation sectors. It provides financing for pre-seed, seed, early and later stage capital requirements. | Finance |
Gigascale Capital
Gigascale Capital Investment ManagersFinance Gigascale Capital invests in companies located in the United States. The firm targets companies operating of clean energy, advanced manufacturing, grid infrastructure and physical AI sectors. It participates in pre-seed, seed and early stage capital requirements. | Finance |
